Article
CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.
Lancet (London, England) - 30 Sept 2023
Taylor-Cousar Jennifer L, Robinson Paul D, Shteinberg Michal, Downey Damian G
Abstract excerpt
Following discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in 1989 and subsequent elucidation of the varied CFTR protein abnormalities that result, a new era of cystic fibrosis management has emerged-one in which scientific principles translated from the bench to the bedside have enabled us to potentially treat the basic defect in the majority of children and adults with cystic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
